1. Home
  2. PRPH

as 06-06-2025 2:40pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Founded: 1989 Country:
United States
United States
Employees: 96 City: NEW YORK
Market Cap: 15.2M IPO Year: 1997
Target Price: N/A AVG Volume (30 days): 1.9M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.74 EPS Growth: N/A
52 Week Low/High: $0.22 - $4.95 Next Earning Date: 05-20-2025
Revenue: $5,845,000 Revenue Growth: -67.59%
Revenue Growth (this year): 221.82% Revenue Growth (next year): N/A

PRPH Daily Stock ML Predictions

Share on Social Networks: